KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Retained Earnings (2016 - 2025)

Elevance Health (ELV) has disclosed Retained Earnings for 17 consecutive years, with -$543.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 101.54% to -$543.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$543.0 million, a 101.54% decrease, with the full-year FY2024 number at -$1.1 billion, up 12.64% from a year prior.
  • Retained Earnings was -$543.0 million for Q3 2025 at Elevance Health, down from $35.5 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $35.5 billion in Q2 2025 to a low of -$2.8 billion in Q3 2022.
  • A 5-year average of $8.5 billion and a median of -$370.0 million in 2021 define the central range for Retained Earnings.
  • Biggest YoY gain for Retained Earnings was 15149.24% in 2022; the steepest drop was 12552.94% in 2022.
  • Elevance Health's Retained Earnings stood at -$197.0 million in 2021, then skyrocketed by 15149.24% to $29.6 billion in 2022, then crashed by 104.43% to -$1.3 billion in 2023, then rose by 12.64% to -$1.1 billion in 2024, then skyrocketed by 52.66% to -$543.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Retained Earnings are -$543.0 million (Q3 2025), $35.5 billion (Q2 2025), and -$911.0 million (Q1 2025).